Abstract
Infections by herpes simplex virus (HSV) represent an expensive public health problem. Although only rarely a cause of mortality, HSV infections usually cause painful and often distressing lesions and are particularly troublesome since symptomatic recurrent disease is a common outcome once an individual has been infected. Recurrent lesions on the face and genitalia are the most common expression but in some locations, such as the eye, distressing results such as blindness can occur. As regards HSV infections, in 1985 the Committee on Issues and Priorities for New Vaccine Development of the Institute of Medicine set the following goals: a 50% reduction in symptomatic primary infection, a 75% reduction in the number of recurrences and a 60% reduction in the severity of episodes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arnold D, Faath S, Rammensee HG, Schild H (1995) Cross-priming of minor histocompatibility antigen- specific cytotoxic T cells with the heat shock protein gp96. J Exp Med 182:885–889
Bevan MJ (1995) Antigen presentation to cytotoxic T lymphocytes in vivo. J Exp Med 182:639–641
Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL (1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 90:11478–11482
Germain RN (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocytes activation. Cell 76:287–299
Holmgren J, Lycke N, Czerknisky C (1993) Cholera toxin and cholera B subunit as oral mucosal adjuvant and antigen vector systems. Vaccine 11:1179–1184
Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL (1993) Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci USA 90:4942–4946
Kriesel JD, Spruance SL, Daynes RA, Araneo B (1996) Nucleic acid vaccine encoding glycoprotein D2 protects mice from herpes simplex virus type 2 disease. J Infect Dis, In press
Kuklin N, Daheshia M, Karem K, Manickan E, Rouse BT (1997) Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J Virol 71:3138–3145
Kutinova L, Benda R, Kalos Z (1988) Placebo-controlled study with subunit herpes simplex virus vaccine in subjects suffering form frequent herpetic recurrences. Vaccine 6:223–228
Manickan E, Francotte M, Kuklin N, Dewerchin M, Molito C, Gheysen D, Slaoui M, Rouse BT (1995a) Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus though CD4+ Thl + T cells. J Virol 69:4711–4716
Manickan E, Rouse RJD, Yu Z, Wire WS, Rouse BT (1995b) Genetic immunization against herpes simplex virus protection is mediated by CD4 T lymphocytes. J Immunol 155:259–265
Manickan E, Yu Z, Rouse RJD, Wire WS, Rouse BT (1995c) Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP27. Viral Immunol 8:53–61
Mester JC, Rouse BT (1991) The mouse model and understanding immunity to herpes simplex virus. Rev Infect Dis 13:S935–945
Mossmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clones. J Immunol 136:2348–2357
Nair S, Rouse RJD, Bruce BD, Rouse BT (1996) Interaction between macrophages and dendritic cells involves a putative peptide chaperon. Submitted
Nair S, Zhou F, Huang L, Rouse BT (1992a) Class I restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polylysines. J Immunol Methods 152:237–243
Nair S, Zhou F, Reddy R, Huang L, Rouse BT (1992b) Soluble proteins delivered to dendritic cells via pH-sensitive liposome induce primary cytotoxic T lymphocyte response in vitro. J Exp Med 175:609–612
Nguyen L, Knipe DM, Finberg RW (1994) Mechanisms of virus-induced Ig subclass shifts. J Immunol 152:478–484
Pfeifer JD, Wick MJ, Roberts RL, Findley K, Normark SJ, Harding CV (1993) Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:153–177
Rouse RJD, Nair SK, Lydy SL, Bowen JC, Rouse BT (1994) Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins. J Virol 68:5685–5689
Simmons A, Nash AA (1984) Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent diseases. J Virol 53:128–136
Simmons A, Tscharke DC (1992) Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J Exp Med 175:1337–1344
Srivastava PK (1993) Peptide-binding heat shock protein in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation. Adv Cancer Res 62:153–177
Stanberry LR (1996) Herpes immunization - on the threshold. J Eueop Acad Dermatol Venerol 7:120–128
Straus SE, Corey L, Burke RL, Savarese B, Barnum G, Krause PR, Kost RG, Meier JL, Sekulovich R, Adair SF (1984) Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 343:1460–1463
Witmer-Pack MD, Oliver W, Valinsky J, Schuler G, Steinman RM (1987) Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med 166:1484–1498
Wolff TA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Feigner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247:1465–1468
Xiang Z, Ertl HCJ (1995) Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmid expressing cytokines. Immunity 2:129–135
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rouse, B.T. et al. (1998). DNA Vaccines and Immunity to Herpes Simplex Virus. In: Koprowski, H., Weiner, D.B. (eds) DNA Vaccination/Genetic Vaccination. Current Topics in Microbiology and Immunology, vol 226. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80475-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-80475-5_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80477-9
Online ISBN: 978-3-642-80475-5
eBook Packages: Springer Book Archive